Consider Oscar Health (OSCR) as a medium-term investment, with a potential January catalyst from an ACA subsidy vote and a price target of $40 to $50. For a core long-term holding, Hims & Hers (HIMS) is presented as a high-conviction play on the future of healthcare, set to capture customers priced out of traditional insurance. Coinbase (COIN) is another key opportunity, as its expansion into stock trading and derivatives could transform it into a comprehensive financial platform. In cryptocurrency, Solana (SOL) is viewed as a strong buy on any weakness, with a potential price floor noted around the $118 level. Lastly, watch for a potential short-term dip in Bitcoin (BTC) to the $82,000 level as a possible entry point.

Hims & Hers Health, Inc. (HIMS)

• The speaker is supremely confident in HIMS, viewing it as the future of healthcare and a decade-long hold.
• The investment thesis is that as traditional health insurance premiums rise (by as much as 30%), many people will lose their coverage.
• HIMS is positioned to capture these customers by offering healthcare services without insurance, often at a lower cost than traditional co-pays.
  • Examples given include metformin-based pills for weight loss and ED medication.
• A major new offering was highlighted: $199 a year for labs, which is described as extremely cheap compared to the typical cost of a doctor's visit or a full lab panel. This service also includes an AI to help you understand your lab results.
• The speaker believes that customers losing insurance from providers like Oscar and others will find the HIMS offering very attractive.

Takeaways

• Sentiment: Very Bullish (Long-term).
• Strategy: The speaker sees HIMS as a core long-term holding. The recent downturn in the stock price is viewed as an annoyance rather than a fundamental problem, with the belief that the market will eventually recognize the company's value ("the market will become a weighing machine at some point again").
• Catalyst: The primary driver is the increasing unaffordability of traditional health insurance, pushing consumers toward direct-to-consumer alternatives like HIMS. The new, low-cost lab testing service is a significant product that could accelerate customer growth.

Oscar Health, Inc. (OSCR)

• The stock has seen a "precipitous decline" recently. The speaker attributes this to the market's short-term focus.
• A vote on the extension of Affordable Care Act (ACA) subsidies, which would benefit Oscar, was delayed until January. The market sold off the stock because the vote isn't happening before Christmas.
• Bullish Factors Ignored by the Market:
  • Oscar is raising its insurance premiums significantly, in some cases by 30%.
  • Management expects to lose less profitable, "higher morbidity" (sicker) customers while retaining healthier ones who can afford the new premiums.
  • The management team is so confident about profitability that they are concerned they "might make too much money" and have to issue rebates to customers to comply with medical loss ratio regulations.
• Valuation: The speaker notes that on their custom metric (enterprise value / gross profit / revenue growth), OSCR is five times cheaper than HIMS.
• Price Target & Timeline: The speaker views OSCR as a "few years hold" and mentioned a specific price target of $40 to $50 to sell the stock.

Takeaways

• Sentiment: Bullish (Medium-term).
• Strategy: This is presented as a medium-term investment opportunity based on a market overreaction. The speaker is holding for a significant price increase.
• Catalysts: The upcoming vote on ACA subsidies in January is a major near-term catalyst. The company's strategy of raising premiums to improve profitability is a core fundamental driver.
• Risks: The speaker explicitly states a general dislike for insurance companies due to their vulnerability to regulation and "the whims of politics."

Coinbase Global, Inc. (COIN)

• The speaker believes Coinbase had a "monumental event" and a "most bullish day" with recent announcements, but the market unfairly sold the stock off by 2%.
• Coinbase is seen as a major threat to traditional brokers like Schwab and Fidelity, and even a "very serious competition" to Robinhood.
• Major New Initiatives:
  • Entering the stock market: Coinbase will now allow users to buy stocks.
  • Derivatives: They are launching 10x perpetual futures (perps) on stocks soon.
  • Prediction Markets: They are launching their own competitor to platforms like Polymarket.
  • On-Chain Innovation: The speaker is excited about the future possibilities this enables, such as staking stocks or creating liquidity provider pairs (e.g., USDC/Tesla) for yield farming.
• The core thesis is that Coinbase is positioning itself to be the leading, US-compliant exchange for all assets as finance moves onto the blockchain.

Takeaways

• Sentiment: Extremely Bullish.
• Strategy: The speaker sees the market's negative reaction as a complete disconnect from fundamentals. The investment thesis is based on Coinbase becoming the foundational platform for the future of finance, where stocks and other assets are traded on-chain.
• Catalysts: The rollout of stock trading and stock-based perpetual futures could attract a massive new user base and trading volume. This expansion makes COIN more than just a crypto exchange; it's becoming a full-fledged, innovative financial platform.

Bitcoin (BTC)

• The speaker believes the fundamental environment for cryptocurrency has "never been so bullish."
• Bullish Factors:
  • Ongoing monetary printing by the Fed, with $40 billion worth of bonds being purchased monthly.
  • A positive regulatory environment where the CFTC, SEC, and bank regulators are "all in."
  • An expected dovish pivot from the Fed ("Mr. Dove") coming in May.
• Price Action: At the time of recording, the price was noted as $84,400. However, the speaker references a chart from "Marty Party" suggesting that market makers may try to push the price down to a liquidation level of $82,000 in the short term.

Takeaways

• Sentiment: Fundamentally Bullish, but cautious on short-term price.
• Strategy: The long-term outlook is very positive due to macroeconomic factors and regulatory clarity. However, investors should be prepared for potential short-term downside. The $82,000 level was mentioned as a potential target for a market-maker-driven shakeout.

Solana (SOL)

• The speaker believes the current downward price action "makes absolutely no sense" when compared to the fundamentals.
• The core belief is that "the future is going to be blockchain," and Solana is a key player.
• Fundamental Strength: The speaker highlights Solana's high transaction throughput, stating it's "only a matter of time until it catches up to Visa and MasterCard."
• Price Action: Referencing the same "Marty Party" chart, the speaker notes that Solana may not go down "much further than 118."

Takeaways

• Sentiment: Very Bullish.
• Strategy: The speaker sees the current price as a significant disconnect from Solana's technological capabilities and future potential. This is viewed as a high-conviction, fundamental play on the growth of blockchain technology. The $118 level was mentioned as a potential floor for the current pullback.